DK0382489T3 - Monoklonalt anti-humant papillomvirusantistof, hybridomcelle, der producerer dette, samt fremgangsmåde til fremstilling deraf - Google Patents

Monoklonalt anti-humant papillomvirusantistof, hybridomcelle, der producerer dette, samt fremgangsmåde til fremstilling deraf

Info

Publication number
DK0382489T3
DK0382489T3 DK90301256.5T DK90301256T DK0382489T3 DK 0382489 T3 DK0382489 T3 DK 0382489T3 DK 90301256 T DK90301256 T DK 90301256T DK 0382489 T3 DK0382489 T3 DK 0382489T3
Authority
DK
Denmark
Prior art keywords
preparation
hybridoma cell
monoclonal anti
human papillomavirus
cell producing
Prior art date
Application number
DK90301256.5T
Other languages
Danish (da)
English (en)
Inventor
Tomoyuki Iwahi
Hiroshi Satoh
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26370930&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0382489(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DK0382489T3 publication Critical patent/DK0382489T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK90301256.5T 1989-02-10 1990-02-06 Monoklonalt anti-humant papillomvirusantistof, hybridomcelle, der producerer dette, samt fremgangsmåde til fremstilling deraf DK0382489T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3237489 1989-02-10
JP23923389 1989-09-15

Publications (1)

Publication Number Publication Date
DK0382489T3 true DK0382489T3 (da) 1995-01-16

Family

ID=26370930

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90301256.5T DK0382489T3 (da) 1989-02-10 1990-02-06 Monoklonalt anti-humant papillomvirusantistof, hybridomcelle, der producerer dette, samt fremgangsmåde til fremstilling deraf

Country Status (10)

Country Link
US (1) US5013743A (de)
EP (1) EP0382489B1 (de)
AT (1) ATE114114T1 (de)
CA (1) CA2009741C (de)
DE (1) DE69014141T2 (de)
DK (1) DK0382489T3 (de)
ES (1) ES2066120T3 (de)
FI (2) FI100168B (de)
GR (1) GR3014973T3 (de)
NO (1) NO900639L (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338723A (en) * 1989-10-13 1994-08-16 Merck & Co., Inc. Fibrinogen receptor antagonists
DK0548103T3 (da) * 1990-09-14 2002-04-02 Byk Gulden Lomberg Chem Fab Anvendelse af pyridylmethylsulfinyl-1H-benzimidazolderivater til behandling af sygdomme, der er fremkaldt af Helicobacter-bakterier
TW209174B (de) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
IS3990A (is) * 1992-04-24 1993-10-25 Ab Astra Aðferð við að blanda saman efni sem hindrar flæðimagasýru og bakteríueyðandi efnis sem brotnar niður í súru umhverfi
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions
KR0144793B1 (ko) * 1992-07-08 1998-07-15 제임스 클리프튼 보올딩 돼지에서 위궤양을 완화시키기 위한 벤즈이미다졸
CZ284249B6 (cs) * 1992-07-28 1998-10-14 Astra Aktiebolag Injekce a injekční souprava obsahující omeprazol a jeho analogy
DE69302646T2 (de) * 1992-08-21 1996-10-31 Eisai Co Ltd Benzimidazolverbindungen als Antibiotika gegen Campylobacter pylon
EP0673246A1 (de) * 1992-12-10 1995-09-27 Byk Gulden Lomberg Chemische Fabrik GmbH Verwendung von alkylthiopyridinen zur bekämpfung von heliobacter-bakterien
JPH06298611A (ja) * 1993-04-16 1994-10-25 Nippon Chemiphar Co Ltd 抗菌剤
CA2166327A1 (en) * 1993-06-29 1995-01-12 Bernhard Kohl Substituted arylthioalkylthiopyridines
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
ATE271555T1 (de) 1998-01-14 2004-08-15 Uab Research Foundation Verfahren zur herstellung und screening von inhibitoren des bakteriellen nad synthetase enzyms, verbindungen daraus und methoden zur behandlung bakterieller und mikrobieller infektionen mit diesen inhibitoren
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
FI104384B (fi) 1998-06-05 2000-01-14 Valmet Corp Laitteisto ja menetelmä viiraveden ja tuoremassan sekoittamiseksi viirakaivon jälkeisessä kanavassa
EP1310252A4 (de) * 2000-08-18 2009-06-10 Takeda Pharmaceutical Injektionen
EP1428825A4 (de) 2001-09-18 2005-03-23 Zeria Pharm Co Ltd Benzimidazolderivate
US9358214B2 (en) * 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
JP2006518751A (ja) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2531564C (en) * 2003-07-18 2016-01-19 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
JP2007522217A (ja) * 2004-02-10 2007-08-09 サンタラス インコーポレイティッド プロトンポンプ阻害剤、緩衝剤および非ステロイド系抗炎症薬の組み合わせ
JP2007532677A (ja) * 2004-04-16 2007-11-15 サンタラス インコーポレイティッド プロトンポンプ阻害剤、緩衝剤、および運動促進薬の組み合わせ
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ709754A (en) * 2004-10-21 2017-02-24 Adare Pharmaceuticals Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
CN101309917B (zh) * 2005-10-06 2013-09-11 奥斯拜客斯制药有限公司 具有增强治疗性质的胃h+，k+-atp酶氘代抑制剂
ES2374730T3 (es) * 2006-03-10 2012-02-21 Arigen Pharmaceuticals, Inc. Nuevo derivado de piridina que tiene actividad contra helicobacter pylori.
US20100297226A1 (en) * 2006-06-01 2010-11-25 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
JP2009539866A (ja) * 2006-06-05 2009-11-19 オースペックス・ファーマシューティカルズ・インコーポレイテッド 置換エリスロマイシンアナログの調製および有用性
EP2068841B1 (de) 2006-10-05 2018-09-26 Santarus, Inc. Neuartige formulierungen von protonenpumpenhemmern und verfahren zu ihrer verwendung
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
US20080103169A1 (en) 2006-10-27 2008-05-01 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
RU2484089C1 (ru) * 2009-04-09 2013-06-10 Ариджен Фармасьютикалз, Инк. Тиопроизводное пиридина и фармацевтическая композиция, которая его содержит и имеет способность действовать против helicobacter pylori
MX2012006240A (es) 2009-12-02 2012-10-03 Aptalis Pharma Ltd Microcapsulas de fexofenadina y composiciones que contienen las mismas.
UY33173A (de) * 2010-01-08 2011-07-29 Eurand Inc
EP3288556A4 (de) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Oral zerfallende zusammensetzungen
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS62277322A (ja) * 1986-02-13 1987-12-02 Takeda Chem Ind Ltd 安定化された腸溶性抗潰瘍固形組成物
JP2694361B2 (ja) * 1989-02-09 1997-12-24 アストラ アクチエボラグ 抗菌剤

Also Published As

Publication number Publication date
ATE114114T1 (de) 1994-12-15
FI104045B (fi) 1999-11-15
FI940951A (fi) 1994-02-28
US5013743A (en) 1991-05-07
FI900662A0 (fi) 1990-02-09
DE69014141D1 (de) 1994-12-22
NO900639D0 (no) 1990-02-09
GR3014973T3 (en) 1995-05-31
ES2066120T3 (es) 1995-03-01
FI940951A0 (fi) 1994-02-28
EP0382489B1 (de) 1994-11-17
NO900639L (no) 1990-08-13
FI104045B1 (fi) 1999-11-15
EP0382489A2 (de) 1990-08-16
FI100168B (fi) 1997-10-15
CA2009741A1 (en) 1990-08-10
EP0382489A3 (de) 1991-06-12
DE69014141T2 (de) 1995-05-24
CA2009741C (en) 1999-03-23

Similar Documents

Publication Publication Date Title
DK0382489T3 (da) Monoklonalt anti-humant papillomvirusantistof, hybridomcelle, der producerer dette, samt fremgangsmåde til fremstilling deraf
KR860004918A (ko) 트리사이클로 화합물의 제조방법
DE69002248D1 (de) 1,2-cyclohexylaminoarylamide zu verwendung als analgetika.
NZ240676A (en) Heterocyclic compounds substituted by a (piperidin-4-yl)-1-oxoalkyl group and pharmaceutical compositions thereof
ES543153A0 (es) Metodo de preparar derivados de b-carbolin-3-oxadiazolilo
FI940229A0 (fi) Trisykliset kondensoituneet heterosykliset yhdisteet, niiden valmistus ja käyttö
RU94022277A (ru) Новые 19-норстероиды, имеющие в положении 11 - бета феноксиалкилсульфонамидную или феноксиалкилсульфонилкарбамидную цепь, метод и промежуточные продукты их получения, и содержащая их фармацевтическая композиция
ATE159728T1 (de) Cis-epoxide derivate, verwendbar als irreversible hiv-protease inhibitoren und verfahren und zwischenprodukte zu ihrer herstellung
DE60235365D1 (de) Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
ATE279424T1 (de) Neue verbindungen kf-1040 und verfahren zu ihrer herstellung
TW362954B (en) Stabilized composition, method for using said composition, and medium containing said
FI952420A (fi) Glukopyranosidibentsotiofeenit
FR2560194B1 (fr) 3-aminoazetidine, ses sels, procede pour leur preparation et intermediaires de synthese
EP1310490A4 (de) Gpr14-antagonisten
YU3099A (sh) Novi derivati eritromicina, postupak za njihovo dobijanje i njihova primena
HU9401214D0 (en) Pyridine derivatives, process for producing them and use of them
WO1998013349A3 (fr) Heteroaryloxyethylamines en tant que ligands 5-ht¿1a?
AU2001295949A1 (en) Process for preparation of optically active sulfonamides and intermediates for their synthesis
EP0881207A4 (de) 2,3-dihalogen-6-trifluormethylbenzol-derivate und verfahren zu ihrer herstellung
NZ329604A (en) Isoxazole derivatives substituted by an amino, guanidinyl or azacycloalkyl-oxy, -sulphinyl or -sulphenyl group, pharmaceutical compositions comprising them
NO993650L (no) Nye forbindelser med hemoregulerende effekt
DE69000335T2 (de) Butalactin, verfahren zu seiner herstellung und seine verwendung als arzneimittel.
MX9700562A (es) Derivado de dihidroferacina, procedimiento para su produccion y farmaco para bacilos de tuberculo y bacilos acido-resistentes atipicos.
CA2443307A1 (en) Quinolone- and naphthyridone-carboxylic acid derivatives